Although the cells that are involved in the axonal sorting defect differ between SMA (motor neurons) and LAMA2 MD (Schwann cells), the human data from SMA patients suggest that early AAV-based intervention may be important to prevent this sorting defect. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.